FINWIRES · TerminalLIVE
FINWIRES

ASX Preview: Australian Shares Set to Rise as Oil Prices Ease; ANZ Group Holdings Posts Higher Fiscal H1 Cash Earnings, Operating Income

By

Australian shares are poised to rise on Friday as oil prices eased from earlier four-year highs amid volatile trading driven by escalating US-Iran tensions and fears over potential disruptions to Middle East crude supplies.

Overnight, the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average rose 1%, 0.9%, and 1.6%, respectively.

In the macroeconomy, the Australian manufacturing sector returned to modest growth in April, though the improvement masked growing strain from Middle East-driven supply chain disruptions, surging fuel costs, and continued weakness in orders and production, according to a survey by S&P Global.

Australia's home value index edged 0.3% higher in April, registering its slowest pace of growth since January 2025 amid declines in Sydney and Melbourne, according to figures from Cotality.

Australia's producer price indexes report is due at 11:30 am Sydney time.

In corporate news, ANZ Group Holdings (ASX:ANZ) reported Friday fiscal first-half cash earnings of AU$1.242 per share on operating income of AU$11.2 billion, compared with cash earnings of AU$1.17 on operating income of AU$11 billion a year earlier.

ResMed (ASX:RMD) reported Friday fiscal third-quarter non-GAAP earnings of $2.86 per share on revenue of $1.43 billion, compared with earnings of $2.37 on revenue of $1.29 billion a year earlier.

Coles Group (ASX:COL) sales revenue for the fiscal third quarter was AU$10.7 billion, up from AU$10.38 billion a year earlier.

Australia's benchmark index fell 0.2% or 21.2 points to close at 8,665.80 on Thursday.

Related Articles

Asia

Joinn Laboratories' Profit Surges 480% in Q1

Joinn Laboratories (HKG:6127, SHA:603127) posted net profit attributable to shareholders of 238.4 million yuan for the first quarter, up 480% from 41.1 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the drug research firm were down over 6% in Thursday's late-morning trade.Earnings per share came in at 0.32 yuan, up from 0.05 yuan a year earlier.Revenue increased 10% to 316.1 million yuan from 287.3 million yuan in the prior-year period.

HKG:6127SHA:603127
Asia

Ganfeng Lithium Turns to Q1 Profit as Revenue Jumps 144%

Ganfeng Lithium (SHE:002460, HKG:1772) posted first-quarter attributable net profit of 1.84 billion yuan, compared with loss of 355.8 million yuan the previous year.Earnings per share stood at 0.88 yuan, versus loss per share of 0.18 yuan last year, according to a Thursday filing with the Shenzhen bourse.Operating revenue jumped 144% year over year to 9.20 billion yuan from 3.77 billion yuan.Shares of the lithium miner were up 2% in recent trade on the Shenzhen bourse and 1% on the Hong Kong bourse.

HKG:1772SHE:002460
Asia

Yihai Kerry Arawana Q1 Profit Up 51%, Revenue Rises 11%

Yihai Kerry Arawana (SHE:300999) posted first-quarter attributable net profit of 1.48 billion yuan, up 51% from 981.4 million yuan the previous year.Earnings per share rose to 0.27 yuan from 0.18 yuan, according to a Thursday filing with the Shenzhen bourse.Operating revenue climbed 11% year over year to 65.5 billion yuan from 59.1 billion yuan.Shares of the food products company were up 2% in recent trade.

SHE:300999